Accelovance Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Accelovance Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010839
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accelovance Inc (Accelovance) is a contract research organization that offers CRO services, patient recruitment, and clinical call center services in various therapeutic areas including oncology, immunization/infectious disease, CNS, renal care and others. The organization’s CRO services include protocol development, project management, clinical trial monitoring, biostatistics, medical writing, data management, and pharmacovigilance services. Accelovance’s clinical call center services comprise surveillance programs, patient-reported outcomes, observational studies, site support services, recruitment, patient market research, and other services. Accelovance provides CRO services to pharmaceutical companies, CROs, biotechs and academic institutions. The company operates in the US, the UK, Israel, Russia, and China. Accelovance is headquartered in Rockville, Maryland, the US.

Accelovance Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accelovance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Accelovance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Accelovance Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Immunicum Enters into Agreement with Accelovance and Midwest Melanoma Partnership 10
Accelovance Enters into Partnership with FHI 360 11
Accelovance and Midwest Melanoma Partnership Enters into Agreement 12
Acquisition 13
Accelovance Acquires CRO Business of THERAMetrics 13
Accelovance Acquires Clinquest and Clinquest Services from Clinquest Group 14
Accelovance Acquires Altair Clinical 15
Accelovance Acquires Radiant Development, Contract Research Organization 16
Accelovance Inc – Key Competitors 17
Accelovance Inc – Key Employees 18
Accelovance Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Accelovance Inc, Pharmaceuticals & Healthcare, Key Facts 2
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Accelovance Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Accelovance Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Accelovance Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Accelovance Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Immunicum Enters into Agreement with Accelovance and Midwest Melanoma Partnership 10
Accelovance Enters into Partnership with FHI 360 11
Accelovance and Midwest Melanoma Partnership Enters into Agreement 12
Accelovance Acquires CRO Business of THERAMetrics 13
Accelovance Acquires Clinquest and Clinquest Services from Clinquest Group 14
Accelovance Acquires Altair Clinical 15
Accelovance Acquires Radiant Development, Contract Research Organization 16
Accelovance Inc, Key Competitors 17
Accelovance Inc, Key Employees 18
Accelovance Inc, Other Locations 19
Accelovance Inc, Subsidiaries 20

★海外企業調査レポート[Accelovance Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • B3 S.A.
    B3 S.A. - Strategy, SWOT and Corporate Finance Report Summary B3 S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Wipro Ltd:企業のM&A・事業提携・投資動向
    Wipro Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wipro Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • WD-40 Company (WDFC):企業の財務・戦略的SWOT分析
    Summary WD-40 Company (WD-40) is a lubricant distributor. The company develops and markets maintenance products, and homecare and cleaning products. Its products are used in rust and corrosion resistive, penetrates stuck parts, and moisture barriers. WD-40 also provides surface cleaners and automati …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Refocus Group Inc:製品パイプライン分析
    Summary Refocus Group Inc (Refocus Group) is a medical equipment company that concentrates on research and development of treatments for human vision disorders. The company has developed visability implant system (VIS) for the treatment of presbyopia. Its VIS procedure is an outpatient procedure tha …
  • Empire Co Ltd:企業の戦略・SWOT・財務情報
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Porcelanosa Grupo AIE:企業の戦略・SWOT・財務情報
    Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report Summary Porcelanosa Grupo AIE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Pier 1 Imports, Inc.:戦略・SWOT・企業財務分析
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ERBA Molecular Ltd:企業の製品パイプライン分析2018
    Summary ERBA Molecular Ltd (ERBA Molecular), formerly Lumora Ltd, a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics. The company provides technology that is used in medical diagnostics, agricultural, livestock and crops, food …
  • Andritz AG (ANDR):企業の財務・戦略的SWOT分析
    Andritz AG (ANDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CenterPoint Energy Inc (CNP):石油・ガス:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Ethan Allen Interiors Inc. (ETH):企業の財務・戦略的SWOT分析
    Ethan Allen Interiors Inc. (ETH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Toray Industries Inc (3402):製薬・医療:M&Aディール及び事業提携情報
    Summary Toray Industries Inc (Toray) is a provider of advanced materials. The company's product portfolio includes fibers, fashion apparel, plastics, chemicals, IT-related products, composite materials, life sciences products, and medical devices, pharmaceuticals, and optical products. It provides i …
  • Petroleos Mexicanos-エネルギー分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • Wesco Aircraft Holdings Inc:企業の戦略・SWOT・財務分析
    Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Abu Dhabi Water & Electricity Authority:電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi Water & Electricity Authority (ADWEA) is a government-owned organization provides utility services. The authority researches and develops methods for the production, distribution and consumption of water and electricity efficiently. Through subsidiaries, ADWEA conducts generation, …
  • Renewable Energy Group, Inc.:企業の戦略・SWOT・財務分析
    Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Renewable Energy Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Elbit Systems Ltd:戦略・SWOT・企業財務分析
    Elbit Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary Elbit Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆